- •Legitimate GLP-1 telehealth includes a real clinician evaluation, a licensed pharmacy, and follow-up care — not just a checkout cart.
- •Costs range widely: brand medications through insurance can be $0–$25 with coverage, cash brand runs ~$499–$1,349/month, and compounded programs often run ~$149–$299/month.
- •As of 2025–2026, semaglutide and tirzepatide are no longer on the FDA shortage list, which tightened the rules around compounded versions.
- •Red flags include no medical visit, no licensed clinician, prices that seem too good to be true, and ‘research chemical’ or ‘not for human use’ labeling.
- •Telehealth is a convenient path, but you still need honest medical history disclosure and monitoring for it to be safe.
Can you really get a GLP-1 prescription online?
Yes — you can legitimately get a GLP-1 prescription online, and telehealth has become one of the most common ways people start treatment. The process works like this: you complete a health questionnaire, share your medical history and often lab work, and then a licensed clinician (a physician, nurse practitioner, or physician assistant) reviews your case and, if appropriate, writes a prescription. That prescription is either sent to a retail or mail-order pharmacy for a brand-name drug like Wegovy or Zepbound, or filled as a compounded version through a licensed compounding pharmacy. What makes telehealth legitimate rather than risky is the presence of a genuine clinical evaluation and ongoing care — a real provider who can adjust your dose, answer questions, and monitor side effects. Telehealth cannot skip the medicine of it: a trustworthy service still needs your accurate medical history, screens for contraindications like a personal or family history of medullary thyroid cancer, and follows up. If a website lets you buy a GLP-1 with no medical review at all, that is a warning sign, not a convenience.
How much does GLP-1 telehealth cost in 2026?
GLP-1 telehealth costs vary enormously depending on whether you get a brand drug or a compounded one, and whether insurance is involved. With insurance coverage and a savings card, brand-name semaglutide or tirzepatide can cost as little as $0–$25 a month, though coverage for weight loss specifically remains inconsistent. Paying cash for brand medication is the most expensive route — roughly $499 a month for the manufacturer's direct cash programs (such as single-dose vial offerings) and up to about $1,000–$1,349 at full retail. Compounded programs through telehealth are usually the cheapest, often in the range of $149–$299 a month with medication included, which is why they surged in popularity. Consultation-only telehealth (where they write a prescription you fill elsewhere) may charge a smaller visit or membership fee, sometimes $50–$99. Always check whether the advertised price includes the medication, the visit, and follow-ups, or just one piece. For a deeper look at lowering brand costs, see our guides on [GLP-1 savings cards and cash prices](/blog/glp1-savings-cards-cash-prices-lower-cost-2026) and [using FSA/HSA dollars for GLP-1](/blog/glp1-fsa-hsa-pre-tax-dollars-save-on-weight-loss-2026).
| Path | Typical monthly cost | Notes |
|---|---|---|
| Brand + insurance + savings card | $0–$25 | Depends on plan covering weight loss |
| Manufacturer cash (single-dose vials) | ~$499 | Brand, no insurance needed |
| Full retail brand, cash | $1,000–$1,349 | Most expensive route |
| Compounded via telehealth | $149–$299 | Cheapest; tighter rules since shortage ended |
What changed for compounded GLP-1 in 2025–2026?
The biggest shift is that compounded semaglutide and tirzepatide are no longer broadly permitted the way they were during the shortage. Compounding pharmacies are generally allowed to make copies of a brand drug only when that drug is on the FDA's official shortage list. During 2022–2024, both semaglutide and tirzepatide were in shortage, which opened the door to a large compounded market sold through telehealth at low prices. The FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in early 2025, and set deadlines after which mass compounding of these drugs should stop. This means some telehealth companies pivoted — to brand medications, to personalized ‘503A’ compounding for individual medical needs, or to different formulations. If you are considering a compounded product in 2026, ask the provider directly how they are legally sourcing it and which licensed pharmacy fills it. Our comparison of [compounded vs brand GLP-1](/blog/compounded-vs-brand-glp1-whats-the-difference) explains the quality and legal differences in detail so you can ask the right questions.
How do you spot a safe versus sketchy GLP-1 seller?
A safe GLP-1 telehealth provider always includes a real medical evaluation by a licensed clinician, uses a licensed U.S. pharmacy you can verify, and offers a way to reach a provider for follow-up and side effects. Look for transparency: the company should tell you the clinician's credentials, the pharmacy's name and state licensure, and exactly what you are paying for. Red flags are hard to miss once you know them: no medical visit or questionnaire at all, no named prescriber, prices dramatically below every legitimate option, requests to pay by wire or crypto, products labeled ‘for research use only’ or ‘not for human consumption,’ shipments from overseas, and no way to contact anyone if something goes wrong. Sourcing GLP-1 from unverified online sellers or grey-market vials is genuinely dangerous — the FDA has warned about counterfeit semaglutide with unknown contents and dosing. When in doubt, verify the pharmacy through your state board of pharmacy, and remember that a slightly higher price from a legitimate provider buys you safety and real medical oversight.
Is telehealth a good fit for you?
Telehealth is a strong fit if you want convenience, live far from an obesity-medicine clinic, or simply prefer handling appointments from home — but it works best when you treat it as real medical care, not online shopping. Be fully honest about your medical history, including any history of pancreatitis, gallbladder disease, thyroid cancer (medullary thyroid carcinoma or MEN2), or eating disorders, since these affect whether a GLP-1 is safe for you. Expect a good provider to ask about these and to want periodic check-ins. Telehealth may be less ideal if you have complex medical conditions that need in-person exams or if you want your primary care doctor coordinating everything — in that case, a referral to a local obesity-medicine specialist might serve you better. Either way, the medication is the same molecule; what varies is the quality of the care wrapped around it. Choosing a provider who monitors your progress, adjusts your dose thoughtfully, and helps you protect muscle and nutrition will get you far better results than the cheapest cart online.
Ask Lea to help you evaluate a provider
Choosing a GLP-1 telehealth provider can feel overwhelming when every ad promises the lowest price. Lea can help you compare your options, understand what a fair price includes, and build a list of questions to ask any provider before you hand over a credit card.
Frequently asked questions
Lea is an AI health companion trained on landmark clinical studies covering GLP-1 medications and menopause. Our content is evidence-based and regularly updated to reflect the latest research.
This article is for informational purposes only and is not medical advice. Always consult your healthcare provider.
Learn more about LeaHave questions about this?
Ask Lea — she'll apply this directly to your medication, your symptoms, your week.
Talk to Lea